Devyser announced the launch of next generation chimerism analysis solution, strengthening its offering in post-transplant monitoring
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...
News | May 4, 2016
Devyser Holding AB announced at its annual general meeting yesterday the appointment of two new board members, Ernst Westman and Lars Höckenström.
Ernst Westman is CEO of the boule diagnostics group since 22 years. Lars Höckenström is currently a senior adviser at Stockholm corporate finance. Chairman of the board Mia Arnhult comments:
"I am delighted to have Ernst Westman and Lars Höckenström on Devyser’s board. Their combined experience and expertise within both the diagnostics industry and finance will greatly benefit our work.
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...
Read More
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a tender in...
Read More
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...
Read More
Devyser Diagnostics AB (publ), a Swedish molecular diagnostics company, today announces that it has...
Read More